• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Italy·Financial Services·BMED.MI
Share

Banca Mediolanum S.p.A. Stocks

€ 24.14Last Updated 25.08.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Moderate

Recommendation

Hold

Market Cap

€ 20.64B

€ 24.14
Key Takeaways

Risk factor

Significant default risk

Data is available to registered users only
Data is available to registered users only

Profitability factor

Solid dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Banca Mediolanum S.p.A. is an Italian financial institution that delivers a broad spectrum of banking and financial solutions. Its offerings encompass fundamental services like checking accounts, diverse lending options including mortgages, and a variety of payment cards such as debit, credit, and prepaid. Additionally, the company facilitates wealth growth through savings instruments, investment vehicles like stocks and bonds, and brokerage services. Beyond traditional banking, it also provides insurance and retirement planning products. The organization was established in 1982, with its primary operations based in Basiglio, Italy.

Company Valuation

Slightly overvalued
3/7

From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E. Editor's n

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of BMED.MI is 26.7 and suggests 10.5% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommenda

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

26.08.2026 18:05

An analyst identified a stock trading below $30 that could benefit from the AI boom. What are the risks?

26.08.2026 17:45

The Fed's preferred measure of inflation came in slightly above expectations. What's next?

26.08.2026 16:55

Four Russian bankers may have made millions off EU sanctions — FT

26.08.2026 16:25

Revolut has launched its own euro-pegged stablecoin. What is the outlook for this market?

26.08.2026 15:50

A micro-cap artificial heart developer's stock price rose 200% in two days. Why?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026